Intravenous disodium etidronate therapy in spinal cord injury patients with heterotopic ossification (Q72652952)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8259329%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Intravenous disodium etidronate therapy in spinal cord injury patients with heterotopic ossification (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8259329%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

author name string

Banovac K

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8259329%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Gonzalez F

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8259329%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Wade N

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8259329%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Bowker JJ

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8259329%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

publication date

1 October 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8259329%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8259329%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8259329%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8259329%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

660-666

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8259329%20AND%20SRC:MED&resulttype=core&format=json

Soft tissue calcifications in cord lesions.

28 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSC.1993.106

7 January 2021

Heterotopic ossification following hip replacement or spinal cord injury. Two clinical studies with EHDP

1 reference

https://api.crossref.org/works/10.1038%2FSC.1993.106

7 January 2021

Intestinal absorption of disodium ethane-1-hydroxy-1,1-diphosphonate (disodium etidronate) using a deconvolution technique.

1 reference

https://api.crossref.org/works/10.1038%2FSC.1993.106

7 January 2021

Effects of intravenous etidronate disodium on skeletal and calcium metabolism

1 reference

https://api.crossref.org/works/10.1038%2FSC.1993.106

7 January 2021

Effect of etidronate disodium on the interactions between malignancy and bone

1 reference

https://api.crossref.org/works/10.1038%2FSC.1993.106

7 January 2021

Etidronate disodium in the management of malignancy-related hypercalcemia

1 reference

https://api.crossref.org/works/10.1038%2FSC.1993.106

7 January 2021

Neoplastic hypercalcemia: physiologic response to intravenous etidronate disodium

1 reference

https://api.crossref.org/works/10.1038%2FSC.1993.106

7 January 2021

Therapy of hypercalcemia of malignancy

1 reference

https://api.crossref.org/works/10.1038%2FSC.1993.106

7 January 2021

A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone

1 reference

https://api.crossref.org/works/10.1038%2FSC.1993.106

7 January 2021

Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSC.1993.106

7 January 2021

Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSC.1993.106

7 January 2021

Effect of ethane-1-hydroxy-1,1-diphosphonate on ectopic bone formation induced by murine osteosarcoma-derived bone-inducing substance

1 reference

https://api.crossref.org/works/10.1038%2FSC.1993.106

7 January 2021

The long-term skeletal effects of EHDP in dogs

1 reference

https://api.crossref.org/works/10.1038%2FSC.1993.106

7 January 2021

Neurological dysfunction in Paget's disease of the vertebral column

1 reference

https://api.crossref.org/works/10.1038%2FSC.1993.106

7 January 2021

Paget's disease: improvement of spinal cord dysfunction with diphosphonates and calcitonin.

1 reference

https://api.crossref.org/works/10.1038%2FSC.1993.106

7 January 2021

The effects of disodium ethane-1-hydroxy-1, 1-diphosphonate on adjuvant induced arthritis in rats

1 reference

https://api.crossref.org/works/10.1038%2FSC.1993.106

7 January 2021

Comparative antiinflammatory and bone protective effects of two diphosphonates in adjuvant arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSC.1993.106

7 January 2021

Bisphosphonates in vitro specifically inhibit, among the hematopoietic series, the development of the mouse mononuclear phagocyte lineage

1 reference

https://api.crossref.org/works/10.1038%2FSC.1993.106

7 January 2021

Effects of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on interleukin 1 production by macrophages

1 reference

https://api.crossref.org/works/10.1038%2FSC.1993.106

7 January 2021

Identifiers

DOI

10.1038/SC.1993.106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8259329%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference